Home/Filings/4/A/0001567619-19-007332
4/A//SEC Filing

PLATZER ERICH 4/A

Accession 0001567619-19-007332

CIK 0000882361other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 9:15 AM ET

Size

7.3 KB

Accession

0001567619-19-007332

Insider Transaction Report

Form 4/AAmended
Period: 2019-03-19
Transactions
  • Purchase

    Common Shares

    2019-03-19$2.19/sh+5,000$10,970135,000 total
  • Purchase

    Common Shares

    2019-03-19$2.19/sh+15,000$32,835130,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.18 to $2.19, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.18 to $2.20, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001275087

Filing Metadata

Form type
4/A
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 9:15 AM ET
Size
7.3 KB